Home

Research

Contact and Personal Information

Publications

 

 

Information for Prospective Graduate Students

 

Information for Postdoctoral Applicants

 

Dr. Burgess' Book "Organic Chemistry By Inquisition"

 

 

Office Associates

Current Members

Former Members

Pictures Past & Present

Intragroup Notices

 

 

 

 

 

 

 

 

Recent Publications

Kevin Burgess - Google Scholar Citations

H index 61 as of May 2016

Citations in Each Year
Description: http://charts.webofknowledge.com/ChartServer/draw?SessionID=3CVCtMGADz4zPBAmVea&Product=UA&GraphID=TC_BarChart_2 

2016

305     Heterogeneous Phase Transfer Catalysis in Solid Phase Syntheses of Anth-Cyclic Tetrapeptides, D. Xin, K.-Y. Wong, K. Burgess, J. Org. Chem., 2016, in press.

305ref

304     Small Molecules for Active Targeting in Cancer, C. S. Kue, A. Kamkaew, K. Burgess, L. V. Kiew, L. Y. Chung, H. B. Lee, Med. Res. Rev., 2016, 36, 494-575. DOI:10.1002/med.21387

303     Anthranilic Acid-containing Cyclic Tetrapeptides:  At the Crossroads of Conformational Rigidity and Synthetic Accessibility, D. Xin, K. Burgess, Org. Biomol. Chem., 2016, 14, 5049-5058. DOI: 10.1039/C6OB00693K

abstractref303

302     Chitosan-coated poly(lactic-co-glycolic acid)-diiodinated boron-dipyrromethene nanoparticles improve tumor selectivity and stealth properties in photodynamic cancer therapy , L. Chung, K. Burgess, J. Mat. Chem. B, 2016, 12, 1431-1452. DOI:10.1166/jbn.2016.2263

2015

301       Aza-BODIPY Dyes With Enhanced Hydrophilicity, A. Kamkaew, K. Burgess, Chem. Comm., 2015, 51, 10664-7. DOI: 10.1039/C5CC03649F

300        Oligoethylene Glycol-substituted Aza-BODIPY Dyes as Red Emitting ER-Probes, S. Thavornpradit, T. Puangsamlee, A. Kamkaew, D. Xin, N. Wanichacheva, K. Burgess, Org. Biomol. Chem., 2015, 8271-6.  DOI:10.1039/c50b01104c

ref300abs

299         Extended Piperidine-piperidinone Protein Interface Mimics, D. Xin, A. Raghuraman, K. Burgess, J. Org. Chem., 2015, 80, 4450-4458. (DOI:10.1021/acs.joc.5b00300

298         Protein-protein Interface Mimicry By An Oxazoline Piperidine-2,4-dione, X. Li, J. Taechalertpaisarn, D. Xin, K. Burgess, Org. Lett., 2015, 17, 632-635.  DOI:10.1021/ol5036547

ref298abs

297         Targeted PDT Agent Eradicates TrkC Expressing Tumors Via Photodynamic Therapy (PDT), C. S. Kue, A. Kamkaew, H. B. Lee, L. Y. Chung, L. V. Kiew, K. Burgess, Mol. Pharmaceutics, 2015, 12, 212-22. DOI:1021/mp5005564

2014

296         In Vivo Studies of Nanostructure-Based Photosensitizers for Photodynamic Cancer Therapy, S. H. Voon, L. V. Kiew, H. B. Lee, S. H. Lim, M. I. Noordin, A. Kamkaew, K. Burgess and L. Y. Chung, Small, 2014, 10, 4993-5013. DOI:10.1002/smll.201401416

295         Small Molecule Probes that Perturb A Protein-protein Interface In Antithrombin, D. Xin, A. Holzenburg, K. Burgess, Chem. Sci., 2014, 5, 4914-4921. DOI:10.1039/c4sc01295j

ref295abs

294         A Chemoselective Route to b-Enamino Esters and Thioesters, D. Xin, K. Burgess, Org. Lett., 2014, 16, 2108-2110.  DOI:10.1021/ol5005643

294_Abs

293         A Multi-faced Secondary Structure Mimics Based on Piperidine-Piperidinones, D. Xin, L. M. Perez, T. R. Ioerger, K. Burgess, Angew. Chem., Int. Ed., 2014, 53, 3594-3498. DOI:10.1002/anie.201400927

293_Abs

292         Metathesis for Catalyst Design:  Metacatalysis, S. Khumsubdee, K. Burgess, Tetrahedron, 2014, 70, 1326-35.

292_Abs

291         Rosamines Targeting the Cancer Oxidative Phosphorylation Pathway, S. H. Lim, L. Wu, V. Kiew, L. Y. Chung, K. Burgess, H. B. Lee, PLOS One, 2014, 9, e82934. DOI:10.1371/journal.pone.0082934

2013

290         Homo-Roche Ester Derivatives By Asymmetric Hydrogenation and Organocatalysis, S. Khumsubdee, H. Zhou, K. Burgess, J. Org. Chem., 2013, 78, 11948-55. DOI:10.1021/jo401996m

290_abs

289         Double-targeting Using a TrkC-Ligand Conjugated to BODIPY-based PDT Agent, A. Kamkaew, K. Burgess, J. Med. Chem., 2013, 56, 7608-14. DOI:10.1021/jm4012142

289 abs

288         A Comparison Between Oxazoline-imidazolinylidene, -imidazoylidine, -benzimidazoylidine Hydrogenations Catalysts, S. Khumsubdee, Y. Fan, K. Burgess, J. Org. Chem., 2013, 78, 9969-74. DOI:10.1021/jo4013783

288 abs

287         Expanding the Scope of Oligo-pyrrolinone-pyrrolidines as Protein-protein Interface Mimics, A. Raghuraman, D. Xin, L. M. Perez, K. Burgess, J. Org. Chem., 2013, 78, 4823-4833. DOI:10.21/jo400323k

298 abs

286         Evaluating Minimalist Mimics by Exploring Key Orientations on Secondary Structures (EKOS), D. Xin, E. Ko, L. M. Perez, T. R. Ioerger, K. Burgess, Org. Biomol. Chem. 2013, 11, 7789-801. DOI:10.1039/c3ob4184k

286abs

285     Comparison of Asymmetric Hydrogenations of Unsaturated-Carboxylic Acids and -Esters, S, Khumsubdee, K. Burgess, ACS Catalysis, 2013, 3, 237-249.

185abs

284     Highly Stereoselective Syntheses of all 1,2,3-Me,OH,Me Triads via Asymmetric Hydrogenation Reactions, Y. Zhu and K. Burgess, Adv. Synth. Cat., 2013, 355, 107-115. DOI:10.1002/adsc.201200709

284abs

283         Exploring Key Orientations at Protein-Protein Interfaces with Small Molecule Probes, E. Ko, A. Raghuraman, L. M. Perez, T. R. Ioerger, K. Burgess, J. Am. Chem. Soc., 2013, 135, 167-173.  DOI:10.1021/ja3067258

283abs

2012

282     Small Molecule Ligands for Active Targeting of TrkC-expressing Tumor Cells, E. Ko, A. Kamkaew, K. Burgess, ACS Med. Chem. Lett., 2012, 3, 1008-1012. DOI:10.1021/ml300227d

282abstract

281     BODIPY Dyes in Photodynamic Therapy, A. Kamkaew, S. H. Lim, H. B. Lee, L. V. Kiew, L. Y. Chung, K. Burgess, Chem. Soc. Rev., 2012, 42, 77-88.  DOI:10.1039/c2cs3521h

280     Omegatides:  Constrained Analogs of Peptide Primary Sequence, D. Fedoseyenko, A. Raghuraman, E. Ko, K. Burgess, Org. Biomol. Chem., 2012, 10, 921-4. DOI:10.1039/c20b06692k

279     Iridium Catalyzed Enantioselective Hydrogenation of a-Alkoxy and b-Alkoxy Vinyl Ethers, Y. Zhu and K. Burgess, RSC Adv., 2012, 2, 4728-35. DOI:10.1039/c2ra01350a

278     Filling Gaps in Asymmetric Hydrogenation Methods for Acyclic Stereocontrol:  Application to Chirons for Polyketide-derived Natural Products, Y. Zhu and K. Burgess, Acct. Chem. Res., 2012, 45, 1623-36.  DOI:10.1021/ar200145q

278abstract

277      (n4-1,5-Cyclooctadiene)(1-[(4S)-(2-(1-adamantyl)-4-5-dihydrooxazolyl)-ethyl]-3-(2,6-diisopropylphenyl)imidazolin-2-ylidene)iridium(I) Tetrakis(3,5-bis(tribluoromethyl)phenyl)borate, Y. Zhu, K. Burgess, EROS USGS, 2012.

 

Kevin Burgess- Google Scholar Citations